Biopharmaceutical company Athersys of Cleveland said it has been granted a patent that covers non-embryonic multipotent stem cells, their isolation and expansion, and related pharmaceutical compositions.
Athersys granted patent for certain stem cell technology
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You